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Abstract 
Background: Six percent of patients are allergic to penicillin according to their medical records. While this designa‑
tion protects a small number of truly allergic patients from serious reactions, those who are incorrectly labelled may 
be denied access to recommended first line treatment for many infections. Removal of incorrect penicillin allergy may 
have positive health consequences for the individual and the general population.
We aimed to explore primary care physicians’ (PCPs) and patients’ views and understanding of penicillin allergy with a 
focus on clinical management of infections in the face of a penicillin allergy record.
Methods: We conducted an interview study with 31 patients with a penicillin allergy record, and 19 PCPs in the 
North of England. Data were analysed thematically.
Results: Patients made sense of their allergy status by considering the timing and severity of symptoms. Diagnosis of 
penicillin allergy was reported to be ‘imperfect’ with PCPs relying on patient reports and incomplete medical records. 
PCPs and patients often suspected that an allergy record was incorrect, but PCPs were reluctant to change records. 
PCPs had limited knowledge of allergy services. PCPs often prescribed alternative antibiotics which were easy to iden‑
tify. Both patients and PCPs differed in the extent to which they were aware of the negative consequences of incor‑
rect penicillin allergy records, their relevance and importance to their lives, and management of penicillin allergy.
Conclusions: PCPs and patients appear insufficiently aware of potential harms associated with incorrect penicillin 
allergy records. Some of the problems experienced by PCPs could be reduced by ensuring the details of newly diag‑
nosed reactions to antibiotics are clearly documented. In order for PCPs to overturn more incorrect penicillin records 
through appropriate use of allergy services, more information and training about these services will be needed.
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Background
Six percent of patients registered in general practice in 
England and 10% of patients in the US have a penicil-
lin allergy label in their electronic health record [1, 2]. 
For patients who are truly allergic it is important that 
these records are correct, as this safeguards against 
serious/deadly consequences of consuming penicil-
lin. Penicillins have been the most common cause of 
drug-inducted fatal and nonfatal anaphylaxis in the 
US and UK, but fatalities are still rare [3, 4]. However, 
it is also estimated that fewer than 10% of people who 
have a record of penicillin allergy are likely to be truly 
allergic to penicillins [5] and an increase in mortal-
ity has also been associated with having a penicillin 
allergy record [1].
Clinical confirmation of a historical diagnosis of peni-
cillin allergy can be difficult for a number of reasons; 
there is often incomplete or inconsistent documenta-
tion of the reaction in medical records and patients may 
have no or limited recollection of the index event [6, 7]. 
The reasons for incorrect penicillin allergy labelling are 
complex. Sometimes symptoms of infection, such a rash 
caused by a viral illness, can be confused with an allergic 
reaction. Similarly, side effects to a penicillin such as nau-
sea or diarrhoea can also lead to patients being labelled 
as allergic [8]. Understandably, PCPs have also concerns 
about missing penicillin allergy and causing serious reac-
tions, especially if they have access to alternative antibi-
otics [9].
Penicillins are generally highly effective, narrow-
spectrum, inexpensive antibiotics and are the first line 
recommended treatment for many infections. Patients 
with a penicillin allergy record are prescribed penicil-
lin much less frequently and they received a range of 
different antibiotics instead [2]. In observational stud-
ies, patients with incorrect penicillin allergy records 
have been found to have longer hospital stays [10], 
increased risk of surgical site infections [11], treatment 
with potentially less effective and more costly antibiot-
ics [2, 12], and increased rates of infection with Methi-
cillin-resistant Staphylococcus aureus and Clostridium 
difficile compared to non-penicillin allergic patients 
[11–14]
These consequences have been recognised at pol-
icy level with the National Institute for Health and 
Care Excellence (NICE) advising clinicians to “dou-
ble check patients with penicillin allergy” [15]. Ameri-
can Academy of Allergy, Asthma, and Immunology 
also highlighted that penicillin allergy is a top priority 
public concern [16]. Increasing numbers of studies are 
reporting on efforts to de-label patients with a penicil-
lin allergy record in both primary and secondary care 
[17–19]. There is some understanding of patient and 
clinician views of penicillin allergy testing and “de-label-
ling” (removal of records that are found to be incorrect). 
Previous studies highlighted that PCPs felt that patients 
may not want to get tested [20] or may be worried about 
the safety of the test [20], while others described diffi-
culties such as lack of time, not knowing what the refer-
ral criteria were [21] or lacking of access to any testing 
services [22]. Limited questionnaire-based studies high-
lighted that patients were not really aware of penicillin 
allergy testing services but were interested in testing 
[20, 23]. Our previous qualitative study explored in 
detail barriers and facilitators to patients attending, and 
PCPs referring for, penicillin allergy testing and subse-
quent use of penicillins [24]. This study highlighted a 
number of issues needing to be considered to enhance 
the effectiveness of de-labelling programmes [24], 
including the finding that clinicians felt that allergy test-
ing could be beneficial but had limited experience of 
referring patients and similarly, that only patients who 
had experienced negative consequences of having peni-
cillin allergy were motivated to get tested [24]. However, 
there is still limited understanding of both the patient 
and PCP perspectives on penicillin allergy and dela-
belling [25]. The current study builds on this work, by 
addressing an important research gap, identified by a 
number of recent reviews [8, 26] which higlighted that 
the views of patients and clinicians have been missing 
so far and called for qualitative studies to explore these 
views and help support de-labelling efforts [8, 26]. Thus, 
in the current study we have addressed the following 
research question: What are PCPs and patients views 
of penicilin allergy and their experiences of managing 
penicillin allergy in primary care?
Methods
A qualitative study using semi-structured interviews in 
general practice in England. Methods have been previ-




We used purposive sampling to identify participants 
with and without experience of penicillin allergy test-
ing. Patients were identified using two methods: i) an 
audit of clinical records of patients with a (previous) 
record of penicillin allergy who attended a hospital drug 
allergy clinic for penicillin-allergy testing in the North of 
England between April 2015 and April 2017; ii) patients 
with a current record of penicillin allergy registered with 
general practices in the geographical area served by the 
allergy clinic.
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Primary care physicians (PCPs)
We also sought to identify PCPs with and without experi-
ence of referring for penicillin allergy testing. PCPs were 
identified using three methods. Firstly, PCPs working 
in practices with patients who had undergone penicillin 
allergy testing in the hospital allergy clinic were identi-
fied and invited; secondly, physicians working in general 
practices in the geographical areas served by the hospital 
drug allergy clinic were invited; thirdly, PCPs who con-
tacted the local microbiology service with relevant clini-
cal queries during the study period were invited.
All potential participants were sent a recruitment 
pack and asked to contact the research team if they 
were interested in participating. After explaining the 
aims of the study, the interviewer answered any ques-
tions the participants had. If they were still willing to 
take part in the study, an interview was arranged. All 
participants gave written consent to take part in the 
study.
Data collection
Two topic guides (one for patients and one for PCPs; 
provided in the supplementary materials) were devel-
oped based on the primary research questions and 
informed by the existing literature on penicillin allergy 
[25]. Throughout semi-structured telephone inter-
views, participants were encouraged to reflect on issues 
most important to them in relation to penicillin allergy 
and its impact [27]. The interviewer (MW) explained to 
participants that she was a non-clinical social science 
researcher carrying out research to improve health ser-
vices and that she had no links with the allergy clinic. 
After obtaining consent, interviews were conducted, 
audio-recorded and transcribed verbatim. No repeat 
interviews were carried out.
Analysis
Data collection and analysis took place concurrently. All 
interview data were analysed using inductive thematic 
analysis [28, 29]. One author, an experienced, female, 
post-doctoral qualitative researcher (MW), familiarised 
herself with all interviews, and her field notes and then 
coded initial transcripts line-by-line. Codes were com-
pared with one another to create themes using constant 
comparison method [30]. This enabled a development of 
a draft coding framework (based on 19 interviews with 
patients and 9 with PCPs). The remaining interviews were 
then analysed using this flexible framework with changes 
made if needed. The data were managed in NVivo. In 
order to enhance credibility and trustworthiness of anal-
ysis, one third of transcripts was independently coded by 
STC [31]. The final codebook was agreed by all authors 
who included psychologists, a sociologist, a general 
practitioner, professors in health care research and hos-
pital consultants with expertise in allergy, infection and 
delabelling. The participants were sent a summary of the 
findings. Interviews continued until data indicated the-
matic saturation in each participant group [32, 33]. This 
meant that no new findings were identified during the 
data collection stage; this was also assessed at the stage of 
analysis and meant that no new codes and themes were 
identified.
Results
Approximately 100 patients were invited through one 
drug allergy clinic serving a large geographical area 
and 18 responded. In addition, over 100 patients were 
invited in primary care with 29 patients responding. This 
resulted in a total sample of 31 patients (sixteen patients 
were not interviewed as they could either not be con-
tacted or contacted the team after the study reached data 
saturation).
Approximately 140 PCPs were invited via an audit of a 
drug allergy clinic, GP practices in the geographical areas 
served by the hospital drug allergy clinic and the local 
microbiology service. Nineteen participants responded 
(15 through the hospital microbiology service; 3 from 
primary care and 1 through the allergy clinic). This 
resulted in a total sample of 19 PCP participants.
A total of 50 interviews were conducted between 
December 2017 and August 2018 and lasted 20–60 min 
(average 46 min). The mean age of patients was 56 years 
(range 19–72) and 42 for PCPs (34–60). 80% of patients 
(n = 25) and 84% of PCPs (n = 16) were women.
A total of 11 themes were identified from the data. Of 
these, six themes concerned patient and PCP perspec-
tives on penicillin allergy testing and subsequent use of 
penicillin containing antibiotics and are reported in our 
previous paper [24]. The remaining 5 themes focused 
on patient and PCP understanding of penicillin allergy 
and their experiences of managing penicillin allergy in 




Patients varied in their recall of what had happened 
when they were initially diagnosed with a penicil-
lin allergy, mainly due to time since diagnosis. Patients 
reported reflecting on the extent to which they believed 
their allergy record, taking into consideration the timing 
of symptoms and symptom severity. Patients who had 
developed symptoms immediately after taking penicillin 
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and those who had symptoms perceived as severe, for 
example difficulty breathing, seemed to be particularly 
convinced that they were allergic. In contrast, symptoms 
perceived as mild, for example localised rash, appeared to 
make patients doubt their allergies, especially if the diag-
noses was made a long time ago.
I wasn’t ill. I don’t remember being really ill with 
it or anything like that, this rash, it just came and 
went. It wasn’t like I was desperately ill and rushed 
to hospital or anything, but I’ve never actually had 
the nerve to say I wasn’t allergic to penicillin in 
case I did have a reaction but, as I say, it was a long 
time ago and medical knowledge was very different 
in 1959 to what it is now (P29, Female, 72, current 
allergy record).
Patients also queried why they had developed an 
allergy, especially if they were previously able to take 
penicillin. This was often described as a reaction “out 
of the blue”. Most patients were unsure whether their 
allergy status could change over time. Sometimes 
patients tried to make sense of their allergy by finding 
a trigger event which might have caused their allergy, 
such as having a heart transplant, or developing other 
allergies. Some questioned whether their allergy was 
hereditary and mentioned other family members hav-
ing penicillin allergy; this in turn seemed to contrib-
ute to them accepting their diagnosis of penicillin 
allergy.
Well because my mum is allergic to it, I just thought 
it was genetic (P30, Female, 19, previous allergy 
record).
Finally, patients often had limited knowledge about the 
difference between an allergic reaction and a side effect. 
Most talked about their symptoms using these terms 
interchangeably. They seemed to have created a “work-
ing” definition of allergy, which meant that they have 
tried to make sense of what allergy is based on the symp-
toms they have experienced:
I’ve always been aware of the sickness. I’ve always 
been aware of the skin reaction but it’s only that 
I’ve got older that I’ve been aware of the migraine 
style reaction [as part of the allergic reaction] (P6, 
Female, 44, current allergy record).
Impact of allergy on managing health
Patients described to what extent penicillin allergy 
affected their lives. Patients, who believed that their 
allergy was a true allergy, unsurprisingly seemed to be 
more affected by their allergy status. They reported 
looking out for penicillin in prescribed medication, and 
reminding health care professionals that they were aller-
gic each time they got a prescription.
If I see anybody now I have to, although it’s on my 
medical records, I have to say I can’t take penicillin. 
I’ve got that in my phone and in my diary. If I had an 
accident, it’s down that I can’t take penicillin (P18, 
Female, 68, current allergy record).
Similarly, participants who had chronic conditions or 
who were at risk of recurring infections described the 
impact of penicillin allergy. This included having a lim-
ited choice of antibiotics or worrying about running out 
of antibiotics in the future.
It’s just not having those antibiotics available to me, 
it does concern me sometimes that’s what I’m con-
cerned about is am I going to get an antibiotic that’s 
going to be able to get rid of it I guess (P16, Female, 
47, current allergy record).
In contrast, other participants described little or no 
effect of penicillin allergy on their life, especially if they 
rarely took antibiotics. Even participants who believed 
that penicillin was a useful antibiotic were unconcerned 
about not having access to penicillins. This seemed to be 
explained by the belief that alternative antibiotics were 
available to them, if needed. As a result, they did not 
think it was important to find out whether their allergy 
was a true allergy or not.
I don’t think I was concerned [about the diagnosis] 
because there are other antibiotics available (P20, 
Female, 58, current allergy record).
PCP influence on patients’ perceptions of allergy
Participants described how they were guided by their 
PCP in managing their allergy. This process often started 
when they were initially diagnosed, when patients 
accepted the diagnosis of penicillin allergy without 
question.
I was only 13 or 14 and I took it face value. I went 
to see him, had the rash. He looked at me, looked at 
my notes, ‘You’ve had this penicillin injection. That’s 
what it is. It’s caused a reaction.’ I never questioned 
it as a teenage girl. I just thought he knows what he’s 
talking about, he said, ‘So you are allergic to penicil-
lin,’ and I just accepted that (P29, Female, 72, cur-
rent allergy record).
As a result, the majority of patients reported that they 
never really discussed their allergy with their PCP and 
that alternative antibiotics were always prescribed. They 
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appeared to accept this, seeing the PCP as an expert in 
choosing the right treatment.
It was just kind of, ‘Are you allergic to anything? 
Oh wait, you’re allergic to penicillin.’ Then they just 
wouldn’t prescribe it. That was about it, they never 
really discussed taking it further with investigations 
or anything (P3, Female, 47, previous allergy record).
In addition, some patients reported that they would 
take their PCP advice in relation to whether testing or 
in fact taking penicillin, despite current allergy record, 
would be beneficial for them.
I suppose I would have to rely on what the expert 
told me. If they said I needed it to save my life, then 
I would take it but if they could offer me an alter-
native I think I would probably rather explore the 
alternatives given that I know that I could come out 
with a small reaction to the penicillin (P30, Male, 
36, current allergy record).
PCPs
Uncertainties around diagnosing penicillin allergy
PCPs described ways of identifying patients with aller-
gies. They routinely checked patients’ allergies on their 
medical records and described how the electronic sys-
tem reminded them about patient allergies at the point of 
issuing a prescription. They perceived this as an impor-
tant safety measure. In addition, some PCPs routinely 
asked patients about their allergies and recorded them if 
patients reported them. While some PCPs relied mainly 
on the system, others felt that checking with the patient 
each time was essential.
Well, I always ask, because it makes me feel better. 
There is actually a system where if you prescribe 
an antibiotic and they’re allergic to it, it does flash 
up and says, ‘There is a registered intolerance.’ But 
I’m just a bit anxious that I might miss that. There 
are so many pop ups that sometimes you might 
just become a little bit desensitised to them. I don’t 
want to kill anyone, I’m terrified that if I give some-
body an antibiotic and they take it and they’re 
allergic, that they are going to have an anaphylac-
tic reaction and they’re gonna die (P8, 2 years of 
experience).
PCPs tried to gather information from patients about 
the details of their reactions both new and previously 
reported; the aim of this was to check whether it was a true 
allergy or just a side effect but most commonly to under-
stand what happened and to record this information accu-
rately and comprehensively in patient’s medical records.
You have to record what sort of allergic reaction the 
patient had, you complete it so that the next person 
looking at it will have a clear idea of what was the 
allergic reaction or was it a side effect or not (P3, 12 
years of experience).
However, PCPs also reported that the electronic 
records system was imperfect as it often did not differ-
entiate between a side effect and an allergy, which caused 
problems later on.
It is difficult on our system to distinguish between 
allergies and side effects because it just comes up 
as adverse reactions so they would still not get it 
because it is coming up as an adverse reaction 
(P12, 20 years of experience).
As a result, PCPs often doubted whether the allergy 
status was correct. This was especially the case when 
the information from patients and their records was 
very brief and based on a historical diagnosis (e.g. 
records just stating “allergic” or patients not being 
able to recall any details about the allergic reaction) or 
when the medical record was based on family history 
rather than personal experience of an allergic reac-
tion. Many were aware that penicillin allergy is over 
diagnosed.
You can’t be sure and that’s the problem isn’t it? 
You’d like to be able to say ’Ok this patient is defi-
nitely penicillin allergic’ but if the patient has a 
vague recollection that around the same time that 
they had penicillin they had a rash and there’s 
nothing documented in the notes, or if there is 
something documented in the notes it’s not consist-
ent with what the patient is saying it’s very difficult 
to put that in – make a diagnosis (P4, 28 years of 
experience).
PCPs often commented on what they thought con-
stituted an allergic reaction. While there was con-
sensus about an anaphylactic reaction constituting a 
true allergy, beyond that PCPs differed in what symp-
toms they considered to be an allergic reaction and 
included symptoms such as feeling unwell or patients 
having gastrointestinal symptoms. In addition, PCPs 
described how some symptoms, such as rash, made it 
very difficult to diagnose allergy.
Obviously, there are symptoms of allergy like ana-
phylaxis, the difficulty is those slightly vague ones 
where they’ve got a bit of a rash, so actually is 
that a bit of an urticarial rash that you’ve got? Is 
it a bit of a non-specific viral rash in a child? It’s 
difficult to say (P6, 6 years of experience).
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Making prescribing decisions for patients with penicillin 
allergy
PCPs commented on the ease of finding and giving an 
alternative antibiotic for patients with penicillin allergy. 
This was often facilitated by ease of using guidelines, or 
being able to ask for advice.
Prescribing] won’t be that complicated. There’s 
always option B. As I said, it’s actually from our 
local guidance that gave us the options. It’s all very 
well established. It’s not complicated to find an 
option (P5, 19 years of experience).
Finding an alternative antibiotic was seen as difficult 
for only a minority of patients; mainly patients who 
either had recurrent infections or a record of multiple 
allergies.
The worry is [having] more than one allergy to an 
antibiotic; that becomes a problem (P5, 19 years of 
experience).
Despite doubting patient’s allergies, PCPs often made 
the decision not to prescribe penicillin as they felt that 
that they could never be 100% sure that it was not a 
true allergy. They described their worry about “making 
a mistake” and causing someone to have anaphylactic 
shock and as a result facing legal action. They also felt 
that if something was recorded on patient’s medical 
records, they could not “ignore” it.
Obviously first of all do no harm and I don’t want 
the patients to come to harm, of course I don’t but 
then similarly I think it’s a very brave/foolish maybe 
PCP that chooses to ignore a documented penicil-
lin allergy and to give penicillin […] and so that just 
makes me feel nervous because if you get it wrong 
and it causes a death, that sits very uncomfortably 
as I’m sure it would when I was standing in front of 
the GMC and they kind of said well why on earth 
when it clearly says there’s a penicillin allergy on this 
patient’s records, did you give penicillin? It’s kind of 
indefensible isn’t it really (P11, 12 years of experi-
ence).
In contrast, minority of PCPs felt confident to challenge 
allergy label and prescribe penicillin for patients with a 
record of penicillin allergy; this was either for patients 
for whom they struggled to prescribe or for patients for 
whom they believed that penicillin was the best antibi-
otic. This was sometimes triggered by advice from micro-
biology or their experience of successfully challenging 
allergy record previously.
If a penicillin-based antibiotic is the best option, I 
sometimes have a conversation with the patients 
about whether they are happy to have a trial or 
not and the vast majority that I have done that to 
have taken the stuff and have been absolutely fine. 
You do it on a case-by-case basis depending on what 
you think is the most appropriate antibiotic for that 
patient and how you think that person will handle 
the situation if they start to show allergic symptoms 
again or not (P7, 26 years of experience).
A minority of PCPs also had experience of challenging 
allergy records by referring patients for formal testing in 
secondary care. Most PCPs were often uncertain about 
referral criteria and what the testing involved.
I don’t know in detail the services available and I 
suppose it’s just not knowing what is appropriate for 
them to see (P1, 2 years of experience).
PCPs were aware of the consequences of incorrect 
allergy labels, including not providing patients with opti-
mal treatment, reducing number of antibiotic options for 
patients in the future, and potentially prescribing more 
expensive antibiotics or agents with more side effects. 
However, they rarely described any negative consequences 
relevant to patients outside of managing them in primary 
care (e.g. longer hospital stays). Also, the difficulties which 
PCPs did report, were not perceived by them as present 
in their day-to-day management of patients. In turn, they 
felt they had limited importance when making prescribing 
decisions in the present. Only a minority mentioned anti-
biotic resistance as an important consideration.
I definitely think it is an issue, it is a real issue, as 
I am very aware that we are over-labelling patients 
with penicillin allergy that do not have an allergy 
at all and I am aware of the fact that studies are 
showing that patients will fare worse, if they are 
labelled as having penicillin allergy […] so I think it 
is a really big issue but on a day-to-day level we get 
round it at the moment without too much difficulty 
(P12, 20 years of experience)
Discussion
This study fills an important research gap by providing 
an in-depth understanding of patient and PCPs views of 
penicillin allergy and its management in primary care. 
It compliments quantitative descriptive work, which has 
identified the scale of the problem, by bringing to the 
fore the perspectives of the people that really matter, 
namely the prescribers and the patients themselves. Their 
accounts are critical to achieving a deeper understanding 
of the barriers and opportunities for improved clinical 
practice for patient benefit.
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This study highlights a number of novel findings in 
relation to patients’ views of penicillin allergy. Patients 
tried to make sense of their allergy status by consider-
ing timing and severity of symptoms. Overall, they had 
limited understanding of penicillin allergy, including 
what constituted symptoms of allergy versus side effect. 
It seemed that they tried to create their own working 
definition of allergy based on their direct experience. 
These issues have not been explored before, with only 
one previous study briefly assessing patients’ knowl-
edge of penicillin allergy and highlighting that patients 
were not aware that drug allergy can wane over time 
[23]. Our study highlights a need for better awareness 
of the importance of incorrect penicillin allergy records 
by both patients and PCPs. PCPs discussions with 
patients about their penicillin allergy might be benefi-
cial, with a particular focus on the difference between a 
side effect and allergic reactions. This knowledge might 
also increase patient and PCP motivation to engage 
with the process of delabelling.
Both patients and PCPs differed in the extent to which 
they were aware of negative consequences of incorrect 
penicillin allergy records, their relevance and in turn 
importance to their lives and management of penicillin 
allergy. Not surprisingly, patients and PCPs who experi-
enced negative consequences of penicillin allergy were in 
turn more aware of them and saw them as more relevant. 
However, some patients were not aware of the negative 
consequences and some PCPs did not see them as impor-
tant or relevant in primary care. Both patients and PCPs 
may also benefit from more information about potential 
negative consequences of penicillin allergy. While this 
does not mean that this will and should lead to delabel-
ling decision, it may help PCPs and patients to have more 
informed discussions about managing penicillin allergy 
in primary care.
In line with previous research on PCPs experiences 
of managing drug allergy in general [34], in the current 
study, PCPs described a number of difficulties in diag-
nosing penicillin allergy. They highlighted that medical 
records and patient reports of events were often incom-
plete, which contributed to diagnostic uncertainty. This 
meant that while PCPs doubted that some patients were 
truly allergic, they were also reluctant to change medical 
records. The current study highlighted two issues, which 
seemed to influence PCP decision making in relation 
to penicillin prescribing. Firstly, PCPs found it easy to 
manage the majority of patients with a penicillin allergy 
as guidelines were clear on what to prescribe as second-
line and the alternatives were easily available. Secondly, 
this decision was often reinforced by PCPs being worried 
about inadvertently causing an allergic reaction. These 
issues have been raised by previous research conducted 
in secondary care; one study reported that while almost 
60% of hospital consultants and doctors in training 
agreed that it is always better to “play it safe” and not use 
beta-lactams in patients labelled penicillin-allergic [9], 
more than 90% also disagreed with the statement that 
“accurate allergy history is not important when making 
prescribing decisions because there are many alternatives 
to beta-lactams that have comparable efficacy and safety” 
[9]. Similarly, another study also found that one of the 
major factors influencing prescribing behaviour was the 
ready availability of alternate antibiotics [35]. The current 
study extends this knowledge and highlights factors spe-
cific to primary care.
Our study also highlights the need to support PCPs 
in order for them to be able to carry out delabelling. 
Recently, new models of delabelling have been pro-
posed; for example, through supporting clinicians to 
use of an algorithm, a structured interview or a clini-
cal decision tool for patients reporting drug allergy 
to establish whether harm was caused by medication 
[36–38]. Using a decision support tool or algorithm 
might be useful for PCPs in order to ensure a consistent 
approach across primary care. This might be a particu-
larly beneficial approach for low risk patients, for exam-
ple patients with likely non-immunological reactions 
who still hold a record of penicillin allergy [29–31]. For 
patients when there is still uncertainty, this approach to 
de-labelling could be complemented by secondary care 
specialist allergy services. A number of barriers need 
to be addressed though. First, there is a need to ensure 
that PCPs have access to penicillin allergy clinics. Sec-
ondly, where these are available, PCPs need to be aware 
of such services and know the referral process and crite-
ria. Thirdly and perhaps most importantly, PCPs need to 
be convinced in the benefits of allergy services for their 
patients [25].
Strengths and limitations
This is the first qualitative interview study to provide an 
in-depth understanding of patient and PCP views and 
experiences of managing penicillin allergy in UK primary 
care. It builds on our previous work which focused on 
identifying barriers and facilitators to penicillin allergy 
testing and subsequent antibiotic use [24]. As previous 
studies used mainly survey designs and only included 
hospital physicians, this study fills an important gap by 
providing a comprehensive account of patient and PCP 
perspectives. The study also benefited from a multidisci-
plinary team working on the analysis which enhanced the 
trustworthiness of data. However, both patients and PCP 
were a convenience sample recruited from one region in 
England which means that these findings may have to be 
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interpreted cautiously in terms of their transferability to 
other settings.
Conclusions
Both patients and PCPs need to be provided with infor-
mation about the negative consequences of incorrect 
penicillin allergy records, their relevance and supported 
to facilitate processes of delabelling, where appropriate.
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